Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Acromegaly – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insights…
The European Commission (EC) has licensed Dupixent (dupilumab), developed by Regeneron and Sanofi, for older than 12 patients as an add-on maintenance treatment for severe asthma with type 2 inflammation.
–Financial Matters Expert to Serve as Chair of Audit Committee– SAN FRANCISCO–(BUSINESS WIRE)–Dance Biopharm Holdings, Inc., a privately-held clinical stage…
Positive Phase 1 results in adult glioma patients supported pediatric brain cancer clinical program—now in pivotal studies SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BLZ100?src=hash"…
GERMANY-based contract development and manufacturing organization (CDMO) Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line to meet increasing demand for its specialist oncolytic virus and viral vector manufacturing services.
Denali has reported net loss of $39.0 million in the first quarter 2019, compared with a net loss of $23.7 million same period last year.
Takeda sells Xiidra to Novartis for up to$5.3 billion, TachoSil to Ethicon for approximately $400 million
Bicycle Therapeutics today announced two senior appointments to facilitateits expanding and advancing clinical pipeline.
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis
Systemic Lupus Erythematosus (SLE), also known as lupus, is a chronic,inflammatory, autoimmune disease affecting 5 million people worldwidewith 70%-90% of these cases appearing in females